Testing effectiveness (Phase 2)Not Yet RecruitingNCT07385989
What this trial is testing
Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma
Who this might be right for
Extranodal NK/T-cell Lymphoma
WEI XU 40